Zhejiang CONBA Pharmaceutical Co Ltd (600572) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥133.43 Million ≈ $19.52 Million USD) by net assets (CN¥7.16 Billion ≈ $1.05 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhejiang CONBA Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2024)

This chart illustrates how Zhejiang CONBA Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Zhejiang CONBA Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.

Zhejiang CONBA Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang CONBA Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Makalot Industrial Co Ltd
TW:1477
0.171x
Yunnan Salt & Salt Chemical Industry Co Ltd
SHE:002053
0.032x
Qingdao Gaoce Technology Co Ltd
SHG:688556
0.024x
PLUXEE NV
PA:PLX
0.434x
Mister Car Wash, Inc. Common Stock
NYSE:MCW
0.083x
Choice International Limited
NSE:CHOICEIN
-0.049x
Metrics Master Income Trust
AU:MXT
0.036x
Fagron NV
BR:FAGR
0.167x

Annual Cash Flow Conversion Efficiency for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang CONBA Pharmaceutical Co Ltd from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see 600572 stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥6.91 Billion
≈ $1.01 Billion
CN¥1.01 Billion
≈ $148.16 Million
0.146x +19.80%
2023-12-31 CN¥7.35 Billion
≈ $1.08 Billion
CN¥898.64 Million
≈ $131.50 Million
0.122x -22.50%
2022-12-31 CN¥7.32 Billion
≈ $1.07 Billion
CN¥1.16 Billion
≈ $169.08 Million
0.158x +31.05%
2021-12-31 CN¥7.39 Billion
≈ $1.08 Billion
CN¥889.94 Million
≈ $130.23 Million
0.120x -48.47%
2020-12-31 CN¥5.35 Billion
≈ $782.79 Million
CN¥1.25 Billion
≈ $182.87 Million
0.234x +24.76%
2019-12-31 CN¥4.94 Billion
≈ $723.27 Million
CN¥925.50 Million
≈ $135.43 Million
0.187x +98.73%
2018-12-31 CN¥5.79 Billion
≈ $847.64 Million
CN¥545.78 Million
≈ $79.86 Million
0.094x -22.70%
2017-12-31 CN¥5.84 Billion
≈ $855.11 Million
CN¥712.27 Million
≈ $104.23 Million
0.122x -43.59%
2016-12-31 CN¥4.49 Billion
≈ $656.77 Million
CN¥969.71 Million
≈ $141.90 Million
0.216x +18.66%
2015-12-31 CN¥4.57 Billion
≈ $668.05 Million
CN¥831.26 Million
≈ $121.64 Million
0.182x -0.61%
2014-12-31 CN¥3.37 Billion
≈ $493.18 Million
CN¥617.43 Million
≈ $90.35 Million
0.183x +101.72%
2013-12-31 CN¥2.59 Billion
≈ $379.22 Million
CN¥235.36 Million
≈ $34.44 Million
0.091x -9.81%
2012-12-31 CN¥2.44 Billion
≈ $357.14 Million
CN¥245.76 Million
≈ $35.96 Million
0.101x -13.82%
2011-12-31 CN¥1.61 Billion
≈ $235.90 Million
CN¥188.36 Million
≈ $27.56 Million
0.117x +59.22%
2010-12-31 CN¥1.72 Billion
≈ $251.12 Million
CN¥125.93 Million
≈ $18.43 Million
0.073x -45.11%
2009-12-31 CN¥1.15 Billion
≈ $167.90 Million
CN¥153.39 Million
≈ $22.45 Million
0.134x +24.75%
2008-12-31 CN¥919.66 Million
≈ $134.58 Million
CN¥98.56 Million
≈ $14.42 Million
0.107x +14.52%
2007-12-31 CN¥854.74 Million
≈ $125.08 Million
CN¥79.98 Million
≈ $11.70 Million
0.094x -17.51%
2006-12-31 CN¥627.66 Million
≈ $91.85 Million
CN¥71.20 Million
≈ $10.42 Million
0.113x -42.62%
2005-12-31 CN¥595.08 Million
≈ $87.08 Million
CN¥117.65 Million
≈ $17.22 Million
0.198x +70.62%
2004-12-31 CN¥565.05 Million
≈ $82.68 Million
CN¥65.47 Million
≈ $9.58 Million
0.116x -58.37%
2003-12-31 CN¥239.44 Million
≈ $35.04 Million
CN¥66.64 Million
≈ $9.75 Million
0.278x --

About Zhejiang CONBA Pharmaceutical Co Ltd

SHG:600572 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.65 Billion
CN¥11.29 Billion CNY
Market Cap Rank
#7028 Global
#1646 in China
Share Price
CN¥4.45
Change (1 day)
-0.67%
52-Week Range
CN¥4.06 - CN¥4.94
All Time High
CN¥10.42
About

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nut… Read more